Compound for the treatment of tuberculosis

Details Compound for the treatment of tuberculosis Compound for the treatment of tuberculosis

A - Human Necessities

61

K

A61K 31/4439 (2006.01) A61K 45/06 (2006.01) A61P 31/06 (2006.01)

Patent

CA 2755209

(5R)-3-[4-[1-[(2S)-2,3-dihydroxypropanoyl]-3,6-dihydro-2H-pyridin-4-yl]-3,5- difluoro-phenyl]-5-(isoxazol-3- yloxymethyl)oxazolidin-2-one, or a pharmaceutically- acceptable salt, or an in- vivo-hydrolysable ester thereof, for use in the treatment of Mycobacterium tuberculosis.

La présente invention, qui concerne le (5R)-3-[4-[1-[(2S)-2,3-dihydroxypropanoyl]-3,6-dihydro-2H-pyridin-4-yl]-3,5-difluoro-phényl]-5-(isoxazol-3-yloxyméthyl)oxazolidin-2-one, l'un de ses sels pharmaceutiquement acceptables, ou l'un de ses esters hydrolysables in vivo, est destinée au traitement de Mycobacterium tuberculosis.

Affiliated with

Also associated with

Rating

Compound for the treatment of tuberculosis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compound for the treatment of tuberculosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compound for the treatment of tuberculosis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2089107